Cpap at Delivery Room for Preterm Infants (CPAP-DR)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01024361 |
Recruitment Status : Unknown
Verified December 2009 by University of Sao Paulo.
Recruitment status was: Active, not recruiting
First Posted : December 2, 2009
Last Update Posted : December 23, 2009
|
- Study Details
- Tabular View
- Results Submitted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Mechanical Ventilation Retinal Disease Death Respiratory Tract Disease | Device: CPAP | Phase 4 |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 200 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Prevention |
Official Title: | CPAP Application at Delivery Room at Very Low Birth Weight Infants |
Study Start Date : | January 2009 |
Estimated Primary Completion Date : | December 2009 |
Estimated Study Completion Date : | December 2010 |
Arm | Intervention/treatment |
---|---|
No Intervention: Routine
Routine protocol of the service
|
|
Experimental: CPAP-DR
Infants randomized to this arm will have nasal CPAP installation at delivery room before the 15th minute of life
|
Device: CPAP
CPAP of 5 cm water pressure will be applied within 15 minutes after birth by Neopuff
Other Name: Neopuff |
- Necessity of mechanical ventilation and surfactant during the first 5 days of life [ Time Frame: 5 days ]
- Maternal and infant characteristics associated with CPAP failure during the first 15 minutes of life [ Time Frame: 15 minutes ]
- Incidence of pneumothorax, interstitial emphysema, ductus arteriosus, peri- intra-ventricular hemorrhage, sepsis, necrotizing enterocolitis [ Time Frame: 30 days ]
- Oxygen use [ Time Frame: 28 days ]
- Oxygen use [ Time Frame: 56 days ]
- Oxygen use [ Time Frame: 36 weeks of corrected age ]
- Retinopathies of prematurity [ Time Frame: Hospital stay ]
- Death during hospitalization [ Time Frame: Hospital stay ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | up to 15 Minutes (Child) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:Inborn.
- Birth weight 1000g to 1500g
- No major malformations
Exclusion Criteria:
- Necessity of intubation
- Maternal decision

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01024361
Principal Investigator: | Francisco E Martinez, MD | University of sao Paulo at Ribeirão Preto |
Responsible Party: | Francisco Eulogio Martinez/ Professor Titular, University of Sao Paulo |
ClinicalTrials.gov Identifier: | NCT01024361 |
Other Study ID Numbers: |
120789 FAPESP 06/61388-2 ( Other Grant/Funding Number: FAPESP 06/61388-2 ) |
First Posted: | December 2, 2009 Key Record Dates |
Last Update Posted: | December 23, 2009 |
Last Verified: | December 2009 |
Preterm infants Nasal CPAP Delivery room Newborn |
Respiratory Tract Diseases Retinal Diseases Eye Diseases |